Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dermatological evaluation of GINOCONFORT
RBR-23j2m8Phase 1Not yet recruiting
- Sponsor
- Infinant Health
- Start
- Aug 2020
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial, sponsored by Infinant Health. Planned start Aug 2020; status: not yet recruiting.
Beyond the preview
Go deeper on RBR-23j2m8.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-23j2m8.